What Are the Latest Treatment Strategies for Newly Diagnosed DLBCL?

By Blood Cancer Talks - Last Updated: August 1, 2023

In this episode of “Blood Cancers Talks,” the hosts discuss how to manage patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL) with Pallawi Torka, MD, of the Memorial Sloan Kettering Cancer Center.

This episode provides listeners with an overview of key research in the field, including studies on central nervous system prophylaxis in DLBCL, PET-adapted therapy with R-CHOP, the POLARIX trial, and more.

The hosts also discuss DLBCL data from the 2022 American Society of Hematology Annual Meeting, including updates on REMoDL-B, glofitamab, and epcoritamab.

Advertisement
Advertisement
Advertisement
Editorial Board